64 related articles for article (PubMed ID: 729476)
1. [Rebound regression after additional hormonal treatment with ethinyl oestradiol of metastasising carcinoma of the breast in females: frequency and clinical significance (author's transl)].
Quednau D; Garbrecht M; Stolzenbach G; Nowakowski H
Dtsch Med Wochenschr; 1978 Dec; 103(51):2029-32. PubMed ID: 729476
[TBL] [Abstract][Full Text] [Related]
2. [Additive treatment of metastasizing breast cancer with special reference to postmenopausal age (results of a randomized study)].
Firusian N; Schietzel M
Strahlentherapie; 1976 Sep; 152(3):235-47. PubMed ID: 968923
[TBL] [Abstract][Full Text] [Related]
3. [Metastases of carcinoma of the breast to the choroid in the female (author's transl)].
Stolzenbach G; von Domarus D
Dtsch Med Wochenschr; 1978 May; 103(20):864-7. PubMed ID: 648368
[TBL] [Abstract][Full Text] [Related]
4. [Clinical experience with the depot estrogen Turisteron in the treatment of metastatic breast cancer (author's transl)].
Gürtler R; Tanneberger S; Bodek B; Morack G
Arch Geschwulstforsch; 1982; 52(2):129-39. PubMed ID: 7103689
[TBL] [Abstract][Full Text] [Related]
5. [Anti-oestrogen treatment of metastasising carcinoma of the breast (author's transl)].
Henningsen B; Amberger H
Dtsch Med Wochenschr; 1977 May; 102(19):713-6. PubMed ID: 870301
[TBL] [Abstract][Full Text] [Related]
6. Response to medroxyprogesterone acetate (NSC-26386) as secondary hormone therapy for metastatic breast cancer in postmenopausal women.
Klaassen DJ; Rapp EF; Hirte WE
Cancer Treat Rep; 1976 Mar; 60(3):251-3. PubMed ID: 1260780
[TBL] [Abstract][Full Text] [Related]
7. [Experiences with the combination of ethinyl estradiol and cyclophosphamide in the treatment of progressive metastasizing breast carcinomas in women].
Nowakowski H; Rode P; Ruhstrat K
Dtsch Med Wochenschr; 1971 Nov; 96(48):1855-60. PubMed ID: 5119931
[No Abstract] [Full Text] [Related]
8. Tamoxifen versus ethinyl estradiol in the treatment of postmenopausal women with advanced breast cancer.
Beex L; Pieters G; Smals A; Koenders A; Benraad T; Kloppenborg P
Cancer Treat Rep; 1981; 65(3-4):179-85. PubMed ID: 7237448
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic use of tamoxifen in advanced breast cancer: correlation with biochemical parameters.
Morgan LR; Schein PS; Woolley PV; Hoth D; Macdonald J; Lippman M; Posey LE; Beazley RW
Cancer Treat Rep; 1976 Oct; 60(10):1437-43. PubMed ID: 191185
[TBL] [Abstract][Full Text] [Related]
10. Antiestrogen-induced remissions in stage IV breast cancer.
Manni A; Trujillo J; Marshall JS; Pearson OH
Cancer Treat Rep; 1976 Oct; 60(10):1445-50. PubMed ID: 1021225
[TBL] [Abstract][Full Text] [Related]
11. [A study of complete responders in cases of metastatic breast cancer treated with combination chemotherapy].
Shinagawa K; Ogawa M; Horikoshi N; Inoue K; Mukaiyama T; Fukutani H; Tabata M; Hirano A; Mizunuma N
Gan No Rinsho; 1989 Apr; 35(5):581-6. PubMed ID: 2541272
[TBL] [Abstract][Full Text] [Related]
12. [Hormonal therapy with aromatase inhibitor in advanced breast cancer].
Vrbanec D; Belev B; Pavlinić-Diminić V; Pezerović D; Dusper B; Plestina S; Unusić J
Lijec Vjesn; 1998; 120(10-11):315-8. PubMed ID: 19658346
[TBL] [Abstract][Full Text] [Related]
13. Multidisciplinary curative treatment for disseminated carcinoma of the breast.
Mannes P; Derriks R; Moens R; Laurent C; Dalcq JM
Cancer Treat Rep; 1976 Jan; 60(1):85-9. PubMed ID: 1000521
[TBL] [Abstract][Full Text] [Related]
14. Distribution, frequency, and quantitative analysis of estrogen, progesterone, androgen, and glucocorticoid receptors in human breast cancer.
Allegra JC; Lippman ME; Thompson EB; Simon R; Barlock A; Green L; Huff KK; Do HM; Aitken SC
Cancer Res; 1979 May; 39(5):1447-54. PubMed ID: 427788
[TBL] [Abstract][Full Text] [Related]
15. [Carcinoembryonic antigens (CEA) in patients with metastatic breast cancer under endocrine and therapeutic treatment (author's transl)].
Pompecki R; Schröder G; Garbrecht M; Frahm H
Dtsch Med Wochenschr; 1978 Apr; 103(14):620-2. PubMed ID: 639696
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of metastasizing breast cancer with aminoglutethimide].
Kübböck J; Ludwig H; Aiginger P; Linkesch W; Pötzi P
Acta Med Austriaca; 1982; 9(5-6):221-6. PubMed ID: 7164757
[TBL] [Abstract][Full Text] [Related]
17. Therapeutic effect of tamoxifen versus tamoxifen combined with medroxyprogesterone acetate in advanced breast cancer in postmenopausal women.
Mouridsen HT; Ellemann K; Mattsson W; Palshof T; Daehnfeldt JL; Rose C
Cancer Treat Rep; 1979 Feb; 63(2):171-5. PubMed ID: 376131
[TBL] [Abstract][Full Text] [Related]
18. Phase II study of vorozole (R83842), a new aromatase inhibitor, in postmenopausal women with advanced breast cancer in progression on tamoxifen.
Goss PE; Clark RM; Ambus U; Weizel HA; Wadden NA; Crump M; Walde D; Tye LM; De Coster R; Bruynseels J
Clin Cancer Res; 1995 Mar; 1(3):287-94. PubMed ID: 9815984
[TBL] [Abstract][Full Text] [Related]
19. Ethinyl estradiol and medroxyprogesterone treatment in advanced breast cancer: a pilot study.
Pellegrini A; Massidda B; Mascia V; Ionta MT; Lippi MG; Muggiano A; Carboni E; Robustelli della Cuna G; Bernardo G; Strada MR; Pavesi L
Cancer Treat Rep; 1981; 65(1-2):135-6. PubMed ID: 7226163
[TBL] [Abstract][Full Text] [Related]
20. Norethisterone acetate in the treatment of advanced breast cancer.
Earl HM; Rubens RD; Knight RK; Hayward JL
Clin Oncol; 1984 Jun; 10(2):103-9. PubMed ID: 6734001
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
